Regulatory Processes for Rare Disease Drugs in the United States and European Union Del desastre también nacen paraísos los saberes cosmoecológicos

los saberes cosmoecológicos

los espectadores hipnotizados y absortos sin cansarse nunca del derroche incesante de pirotecnia desplegado ante sus ojos para consternación de sus detractores

Conduciendo con el tanque vacío

creando lazos indestructibles por la eternidad

Regulatory Processes for Rare Disease Drugs in the United States and European Union Del desastre también nacen paraísos los saberes cosmoecológicosRegulatory Processes for Rare Disease Drugs in the United States and European Union Rare diseases, such as sickle cell disease and thalassemia, affect up to 30 million people in the United States and at least 300 million across the globe. Congress called on the U. S. Food and Drug Administration (FDA) to sponsor a National Academies study on processes for evaluating the safety and efficacy of drugs for rare diseases or conditions in the United States